Red Crane Wealth Management, LLC has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity holdings as of September 30, 2026. The filing lists 78 separate positions held by the firm.
The portfolio is heavily weighted toward exchange-traded funds (ETFs), comprising the majority of the disclosed holdings. Key ETFs include Innovator ETFs Trust, which holds 30 distinct funds, and iShares, which lists 13 funds. Notable ETF positions include the iShares Core MSCI EAFE ETF, the Vanguard S&P 500 ETF Shares, and the SPDR Series Trust S&P 500 ETF.
Among individual equities, the portfolio includes significant stakes in Alphabet Inc. Class A and Class C shares, Microsoft Corporation, and Meta Platforms Inc. Class A shares. The firm also holds positions in Amazon.com Inc., Apple Inc., and Amgen Inc.
The top individual equity holding by share count is Lineage Cell Therapeutics Inc., with 506,460 shares. Other notable individual stock positions include Taiwan Semiconductor Manufacturing Co. Sponsored ADRs and Oracle Corp.
